Clinical Trials Logo

Clinical Trial Summary

To evaluate the efficacy and safety of Kangfu Xiaoyan Suppository in the treatment of pelvic inflammatory diseases (dampness-heat accumulation syndrome) and its influence on the sequelae of pelvic inflammatory diseases, and to study the role of traditional Chinese medicine in reducing the use of antibiotics and the risk of clinical medication, taking levofloxacin + metronidazole as the control drug.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04035785
Study type Interventional
Source China Academy of Chinese Medical Sciences
Contact Yanming Xie, BA
Phone 86-13911112416
Email ktzu2018@163.com
Status Not yet recruiting
Phase Phase 4
Start date July 28, 2019
Completion date December 31, 2020

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04031664 - A Clinical Study on Qianjin Capsule of Gynaecology Combined With Antibiotics for Pelvic Inflammatory Diseases (Damp-heat Stasis and Qi Deficiency Syndrome) Phase 4